Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Bellerophon Therapeutics Inc (BLPH)

Bellerophon Therapeutics Inc (BLPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Bellerophon Therapeutics: Q3 Earnings Snapshot AP - Tue Nov 14, 2023

Bellerophon Therapeutics: Q3 Earnings Snapshot

BLPH : 0.0120 (-25.47%)
Bellerophon Therapeutics: Q1 Earnings Snapshot AP - Mon May 15, 2023

Bellerophon Therapeutics: Q1 Earnings Snapshot

BLPH : 0.0120 (-25.47%)
Bellerophon Therapeutics: Q3 Earnings Snapshot AP - Mon Nov 14, 2022

Bellerophon Therapeutics: Q3 Earnings Snapshot

BLPH : 0.0120 (-25.47%)
Bellerophon Announces Poster Presentation at Upcoming American Thoracic Society 2022 International Conference Globe Newswire - Thu May 12, 2022

WARREN, N.J., May 12, 2022 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage...

BLPH : 0.0120 (-25.47%)
Bellerophon Provides Clinical Program Update and Reports First Quarter 2022 Financial Results Globe Newswire - Wed May 11, 2022

WARREN, N.J., May 11, 2022 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage...

BLPH : 0.0120 (-25.47%)
Bellerophon Provides Clinical Program Update and Reports Full-Year 2021 Financial Results Globe Newswire - Thu Mar 31, 2022

WARREN, N.J., March 31, 2022 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage...

BLPH : 0.0120 (-25.47%)

Barchart Exclusives

Spotify Just Raised U.S. Prices. How Should You Play SPOT Stock in January 2026? Barchart - 15 minutes ago
With prices increasing, shares sliding, and leadership changing, is SPOT’s latest move a buying opportunity or a warning sign? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot